After the monoclonal neutralizing antibody is patented, the institute will find an international manufacturer to mass produce it as a treatment.
By Abigail Klein Leichman | posted 5/6/2020
After the monoclonal neutralizing antibody is patented, the institute will find an international manufacturer to mass produce it as a treatment.
By Abigail Klein Leichman | posted 5/6/2020